Cargando…

Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future Perspective

SIMPLE SUMMARY: Recent scientific discoveries identify cell senescence as pivotal in hepatocellular cancer (HCC) biology. Specifically, hepatitis B virus (HBV), hepatitis C virus (HCV) and non-alcoholic fatty liver disease (NAFLD) are major risk factors for HCC occurrence and it seems that cell sene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giannakoulis, Vassilis G., Dubovan, Peter, Papoutsi, Eleni, Kataki, Agapi, Koskinas, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468315/ https://www.ncbi.nlm.nih.gov/pubmed/34572959 http://dx.doi.org/10.3390/cancers13184732

Ejemplares similares

Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics
por: Han, Yeaeun, et al.
Publicado: (2023)

Membranous CD44v6 is upregulated as an early event in colorectal cancer: Downregulation is associated with circulating tumor cells and poor prognosis
por: Kataki, Agapi, et al.
Publicado: (2021)

The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets
por: Rossi, Martina, et al.
Publicado: (2021)

Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data
por: Giannakoulis, Vassilis G., et al.
Publicado: (2020)

Targeting cellular senescence with novel senotherapeutics by design to extend healthspan
por: Zhang, Lei, et al.
Publicado: (2021)

Hallmarks and Biomarkers of Skin Senescence: An Updated Review of Skin Senotherapeutics
por: Bulbiankova, Darya, et al.
Publicado: (2023)

The role of cellular senescence in metabolic diseases and the potential for senotherapeutic interventions
por: Zhang, Huantong, et al.
Publicado: (2023)

Author reply – Letter to the editor “The challenges of quantifying the psychological burden of COVID-19 on heathcare workers”
por: Pappa, Sofia, et al.
Publicado: (2021)

The role of cellular senescence in female reproductive aging and the potential for senotherapeutic interventions
por: Secomandi, Laura, et al.
Publicado: (2021)

Senotherapeutics in Cancer and HIV
por: Sánchez-Díaz, Laura, et al.
Publicado: (2022)

Global burden of COVID-19 pandemic on healthcare workers
por: Papoutsi, Eleni, et al.
Publicado: (2020)

The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice
por: Yoshida, Shota, et al.
Publicado: (2020)

Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection
por: Elsallabi, Osama, et al.
Publicado: (2022)

Senotherapeutic peptide treatment reduces biological age and senescence burden in human skin models
por: Zonari, Alessandra, et al.
Publicado: (2023)

Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies
por: Papoutsi, Eleni, et al.
Publicado: (2021)

Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis
por: Pappa, Sofia, et al.
Publicado: (2020)

Corrigendum to “Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis” [Brain Behav. Immun. 88 (2020) 901–907]
por: Pappa, Sofia, et al.
Publicado: (2021)

Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells
por: Murakami, Takaaki, et al.
Publicado: (2022)

Senotherapeutics and Their Molecular Mechanism for Improving Aging
por: Park, Jooho, et al.
Publicado: (2022)

Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats
por: Malavolta, Marco, et al.
Publicado: (2020)

The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD
por: Radmanić, Leona, et al.
Publicado: (2022)

The Ercc1(-/Δ) mouse model of accelerated senescence and aging for identification and testing of novel senotherapeutic interventions
por: Wong, Alec, et al.
Publicado: (2020)

Biomolecular Evaluation of Piceatannol’s Effects in Counteracting the Senescence of Mesenchymal Stromal Cells: A New Candidate for Senotherapeutics?
por: Alessio, Nicola, et al.
Publicado: (2021)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe
por: Chin'ombe, Nyasha, et al.
Publicado: (2009)

Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics
por: Oguma, Yo, et al.
Publicado: (2023)

HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009)

Fisetin is a senotherapeutic that extends health and lifespan
por: Yousefzadeh, Matthew J., et al.
Publicado: (2018)

Senotherapeutic Effect of Retinaldehyde and Hyaluronate Fragments in Dermatoporosis
por: Kaya, Aysin, et al.
Publicado: (2023)

Impact of chronic schistosomiasis and HBV/HCV co-infection on the liver: current perspectives
por: Omar, Hanan Hassan
Publicado: (2019)

Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
por: Nahon, Pierre, et al.
Publicado: (2021)

In vitro and in vivo toxicity assessment of the senotherapeutic Peptide 14
por: Zonari, Alessandra, et al.
Publicado: (2022)

Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies
por: Dey, Amit K., et al.
Publicado: (2023)

Src Tyrosine Kinase Inhibitors: New Perspectives on Their Immune, Antiviral, and Senotherapeutic Potential
por: Rivera-Torres, José, et al.
Publicado: (2019)

Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review
por: Das, Undurti N.
Publicado: (2018)

Senotherapeutics: emerging strategy for healthy aging and age-related disease
por: Kim, Eok-Cheon, et al.
Publicado: (2019)

Senotherapeutics: An emerging approach to the treatment of viral infectious diseases in the elderly
por: Li, Zhiqiang, et al.
Publicado: (2023)

Senotherapeutics: a possible mitigator of age-related pulmonary disease
por: eBioMedicine
Publicado: (2023)

Current and future pharmacological therapies for NAFLD/NASH
por: Sumida, Yoshio, et al.
Publicado: (2017)

HBV and HCV Infection in Children and Adolescents
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pjehiqq4najc4vv8csavjd02it